|
atherosclerosis |
5 |
|
gut microbiota |
5 |
|
creb |
4 |
|
nitric oxide |
4 |
|
oxidative stress |
4 |
|
alternatively activated macrophages |
3 |
|
antioxidants - pharmacology |
3 |
|
blotting, western |
3 |
|
cell culture techniques |
3 |
|
cell line |
3 |
|
drugs, chinese herbal - pharmacology |
3 |
|
endotoxemia |
3 |
|
gene expression - drug effects |
3 |
|
herbal medicine |
3 |
|
humans |
3 |
|
il-13 |
3 |
|
il-4 |
3 |
|
inducible nitric oxide synthase |
3 |
|
insulin resistance |
3 |
|
labyrinthine zone |
3 |
|
left anterior descending coronary artery ligation |
3 |
|
macrophages - drug effects - enzymology |
3 |
|
mtor |
3 |
|
neonatal heart regeneration |
3 |
|
nitrates - analysis - metabolism |
3 |
|
nitric oxide synthase type ii - antagonists & inhibitors - genetics |
3 |
|
nitrites - analysis - metabolism |
3 |
|
placenta |
3 |
|
plant extracts - isolation & purification - pharmacology |
3 |
|
reishi - chemistry |
3 |
|
rna, messenger - analysis - metabolism |
3 |
|
superoxides - analysis - metabolism |
3 |
|
tetradecanoylphorbol acetate - pharmacology |
3 |
|
th2 immunity |
3 |
|
tlr5 |
3 |
|
adipokine |
2 |
|
apoa1 |
2 |
|
aquaporin 7 |
2 |
|
carotid artery diseases - physiopathology - ultrasonography |
2 |
|
carotid artery, common - physiopathology - ultrasonography |
2 |
|
coronary aneurysm - blood - etiology - physiopathology |
2 |
|
folate |
2 |
|
folic acid |
2 |
|
glucose homeostasis |
2 |
|
glycerol efflux |
2 |
|
homocysteine. |
2 |
|
hydrogen peroxide - blood |
2 |
|
lipocalin |
2 |
|
lipocalin 14 |
2 |
|
macrophages. |
2 |
|
malondialdehyde - blood |
2 |
|
metabolic regulation |
2 |
|
nitric-oxide synthase. |
2 |
|
obesity |
2 |
|
toll-like receptor |
2 |
|
toll-like receptor-5 |
2 |
|
3-hydroxy-3-methylglutaryl coenzyme a reductase |
1 |
|
acute kidney injury |
1 |
|
adiponectin |
1 |
|
angioplasty |
1 |
|
bifurcation |
1 |
|
bioactive components |
1 |
|
camp |
1 |
|
camp response element-binding protein |
1 |
|
chromatographic fingerprinting |
1 |
|
cytokines |
1 |
|
diabetes mellitus |
1 |
|
dietary fat intervention |
1 |
|
folate transporter |
1 |
|
folate transporters |
1 |
|
ginkgo biloba leaf extract |
1 |
|
high fat diet |
1 |
|
high-fat diet |
1 |
|
hmg-coa reductase |
1 |
|
homocysteine |
1 |
|
hyperhomocysteinemia |
1 |
|
integration |
1 |
|
ischemia |
1 |
|
iκb kinase |
1 |
|
iκbα |
1 |
|
liver |
1 |
|
liver function |
1 |
|
macrophage |
1 |
|
mechanisms |
1 |
|
metabolism low-density lipoprotein receptor |
1 |
|
monocyte |
1 |
|
monocyte chemoattractant protein-1 |
1 |
|
monocytes |
1 |
|
mucosa |
1 |
|
nadph oxidase |
1 |
|
natural health product (nhp) regulations |
1 |
|
nonalcoholic fatty liver disease (nafld) |
1 |
|
nuclear factor kappa b |
1 |
|
nuclear factor y |
1 |
|
nuclear factor-κb |
1 |
|
nuclear respiratory factor-1 |
1 |
|
pka |
1 |
|
proton-coupled folate transporter |
1 |
|
reactive oxygen species |
1 |
|
reduced folate carrier |
1 |
|
renal artery stenosis |
1 |
|
standardization |
1 |
|
stenting |
1 |
|
sterol regulatory element-binding protein-2 |
1 |
|
sulfur-containing amino acid |
1 |
|
superoxide |
1 |
|
superoxide anion |
1 |
|
supplementation |
1 |
|
traditional chinese medicine |
1 |
|
tubular cells |
1 |
|
vascular cells |
1 |
